Aspen Aerogels
ASPN
60 hedge funds and large institutions have $115M invested in Aspen Aerogels in 2020 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 23 increasing their positions, 9 reducing their positions, and 9 closing their positions.
156% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 9
133% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 9
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
25% more funds holding
Funds holding: 48 → 60 (+12)
1.59% more ownership
Funds ownership: 68.74% → 70.33% (+1.6%)
11% less capital invested
Capital invested by funds: $130M → $115M (-$14.8M)
Top Buyers
Top Sellers
ASPN Hedge Fund Activity: Q1 2020 in Review
60 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Aspen Aerogels (ASPN) for Q1 2020, worth a combined $115M — down 11% from $130M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new ASPN positions and 9 closed out — a net gain of 12 holders — while 23 added to existing stakes and 9 trimmed.
The largest buyer was Driehaus Capital Management, opening a new position worth an estimated $3.46M. The largest seller was Russell Investments Group, cutting an estimated $2.37M.
- 60 institutional investors held Aspen Aerogels (ASPN) as of Q1 2020, up from 48 in Q4 2019.
- Funds reported $115M of Aspen Aerogels stock for Q1 2020, down 11% quarter-over-quarter.
- 21 funds opened new Aspen Aerogels positions in Q1 2020 and 9 closed out, a net change of +12 holders.
- The largest Aspen Aerogels buyer in Q1 2020 was Driehaus Capital Management, an estimated $3.46M added.
- The largest Aspen Aerogels seller in Q1 2020 was Russell Investments Group, an estimated $2.37M sold.
Based on aggregated 13F filings for Q1 2020.